Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI.

MLA

Sundaresan, Vinaik Mootha, et al. “Risks of Grade Reclassification among Patients with Gleason Grade Group 1 Prostate Cancer and PI-RADS 5 Findings on Prostate MRI.” Urologic Oncology, Dec. 2024. EBSCOhost, https://doi.org/10.1016/j.urolonc.2024.11.007.

APA

Sundaresan, V. M., Webb, L., Rabil, M., Golos, A., Sutherland, R., Bailey, J., Rajwa, P., Seibert, T. M., Loeb, S., Cooperberg, M. R., Catalona, W. J., Sprenkle, P. C., Kim, I. Y., & Leapman, M. S. (2024). Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Urologic Oncology. https://doi.org/10.1016/j.urolonc.2024.11.007

Chicago

Sundaresan, Vinaik Mootha, Lindsey Webb, Maximilian Rabil, Aleksandra Golos, Ryan Sutherland, Jonell Bailey, Pawel Rajwa, et al. 2024. “Risks of Grade Reclassification among Patients with Gleason Grade Group 1 Prostate Cancer and PI-RADS 5 Findings on Prostate MRI.” Urologic Oncology, December. doi:10.1016/j.urolonc.2024.11.007.